https://humanitrack-prod-static.s3.amazonaws.com/quest/6e85891188694b0fab2b9b1f636dfb9f.svg
Epidemic Response

Epidemic Response

Completed: 50%

Quest hub:

Prevention & handling of widespread infectious diseases through science and tech, with focus on COVID-19

Indefinite lifespanPeace on EarthSDG 3: Good health and well-being

Welcome!

Visitors, explore and click the tabs from DATA to EVENTS (scroll left on mobile)

What is our purpose with this Quest?

  • To create agile, interactive, and complete overviews and roadmaps of the technologies driving progress on handling and preventing COVID-19 and future epidemics, and then help accelerate that progress

How?

  • The publicly available databases and roadmaps we create as a community help align all entities working on solutions and identify where to focus efforts and resources for maximum impact
  • Enable anyone, even non-technical people, to take action to fight COVID-19 with science, technology, and innovation via our tasks
  • Provide an open source pre-projecting platform to nurture ideas and breed innovation for new and improved solutions
  • This all leads to making the most of our global resources, collaboration, and impact to accelerate progress on the most ideal, affordable, and sustainable solutions

Want to help?

  • Become a Hero and JOIN NOW (is free, takes 10 minutes here and there)
  • Join our growing volunteering team of researchers, ambassadors, content creators, communicators, moderators...more info and sign-up HERE
  • Spread the word: follow, like, tag, share! Insta LinkedIn FB Twitter
  • Show some love via our Support page

Heroes and volunteers, go take action with a Task, be vocal in the Labs, or post in the newsfeed!

 

Read our community written articles on...

 

Current community goal: Reach 200 followers for this Quest! Expand the Progress Bar above to see the status

Check out our curated list of COVID-19 resources below from our LIBRARY section...

Join to post in feed

Oct 25, 2020

https://www.proactiveinvestors.co.uk/companies/news/932065/open-orphan-moves-forward-with-government-backed-covid-19-vaccine-human-challenge-study-932065.html

Executive chairman Cathal Friel said the contract with the government could be worth up to £40mln. The first volunteers will enter the facility early next year, where they will be exposed to the virus so that the scientists can build a ‘challenge virus’ to then use in the vaccine trials.


0
Leave the first comment

Oct 25, 2020

https://www.newswise.com/coronavirus/research-team-discovers-the-molecular-processes-in-kidney-cells-that-attract-and-feed-covid-19

Although the lungs are a common target for COVID-19’s cytokine storm, so are the kidneys, making the 1 in 4 U.S. adults with diabetes resulting in diabetic kidney disease at increased risk for virus mortality.


0
Leave the first comment

Oct 25, 2020

https://www.weforum.org/agenda/2020/10/how-to-scale-up-the-covid-19-response/

COVID-19 continues to sweep across the globe. Here are 7 of the challenges the pandemic poses to global health security... and 7 ways to counter them.


2
Leave the first comment

Oct 25, 2020

https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19

FDA approved Veklury (remdesivir) for adults and pediatric patients 12 years of age and older for the treatment of COVID-19 requiring hospitalization


2
Leave the first comment

Oct 21, 2020

https://www.sciencemag.org/news/2020/10/could-certain-covid-19-vaccines-leave-people-more-vulnerable-aids-virus

Certain COVID-19 vaccine candidates could increase susceptibility to HIV, warns a group of researchers who in 2007 learned that an experimental HIV vaccine had raised in some people the risk for infection with the AIDS virus.


1
Leave the first comment

Oct 19, 2020

https://www.sciencemag.org/news/2020/10/remdesivir-and-interferon-fall-flat-who-s-megastudy-covid-19-treatments

Solidarity fails to find mortality benefits in four treatments—but the global trial itself wins praise. “We would love to have a drug that works, but it’s better to know if a drug works or not than not to know and continue to use it,” says WHO’s chief scientist, Soumya Swaminathan.


1
Leave the first comment

Oct 19, 2020

https://scitechdaily.com/closing-borders-and-stopping-the-covid-19-virus-who-eu-were-fatally-mistaken/

Countries with international travel restrictions suffered fewer COVID-19 fatalities. Travel restrictions implemented early on in the pandemic have been crucial in slowing the spread of the coronavirus and keeping death rates low. A new study published by Ruud Koopmans, director at the WZB Berlin So


1
Leave the first comment

Oct 15, 2020

https://www.webmd.com/lung/news/20201012/first-confirmed-us-case-of-covid-reinfections

A 25-year-old man from Nevada and a 42-year-old man in Virginia experienced second bouts of COVID-19 about 2 months after they tested positive the first time. Gene tests show both men had two slightly different strains of the virus, suggesting that they caught the infection twice.


2
Leave the first comment

Oct 12, 2020

https://www.cnet.com/health/is-the-coronavirus-airborne-the-scientific-consensus/

Since the early days of the coronavirus pandemic, scientists and doctors have warned of airborne transmission of SARS-CoV-2. Finally, in October 2020 -- seven months into the pandemic -- public health agencies have acknowledged the potential of airborne spread. Here's what you should know about airborne transmission of COVID-19.


2
Leave the first comment

Oct 08, 2020

https://www.wired.com/story/a-global-data-effort-probes-whether-covid-causes-diabetes/

Dozens of case reports have hinted that the coronavirus might trigger the onset of diabetes in people with no history of the disease.


2
Leave the first comment